MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - indian pharma
- ELDER PHARMA - TEVA PHARMA (Israel)
ELDER PHARMA vs TEVA PHARMA (Israel) - Comparison Results
TEVA PHARMA (Israel)
Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
Financials
 ELDER PHARMA  TEVA PHARMA |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| ELDER PHARMA Jun-14 |
TEVA PHARMA Dec-13 |
ELDER PHARMA/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 380 | 3,054 | - | |
| Low | Rs | 188 | 2,653 | - | |
| Sales per share (Unadj.) | Rs | 491.2 | 1,752.6 | - | |
| Earnings per share (Unadj.) | Rs | -3.2 | 109.5 | - | |
| Cash flow per share (Unadj.) | Rs | 14.4 | 251.1 | - | |
| Dividends per share (Unadj.) | Rs | 0 | 95.84 | - | |
| Dividend yield (eoy) | % | 0 | 3.4 | 0.0% | |
| Book value per share (Unadj.) | Rs | 376.5 | 1,946.8 | - | |
| Shares outstanding (eoy) | m | 20.54 | 848.00 | - | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 0.6 | 1.6 | 35.5% | |
| Avg P/E ratio | x | -89.3 | 26.1 | -342.5% | |
| P/CF ratio (eoy) | x | 19.7 | 11.4 | 173.5% | |
| Price / Book Value ratio | x | 0.8 | 1.5 | 51.5% | |
| Dividend payout | % | 0 | 87.5 | 0.0% | |
| Avg Mkt Cap | Rs m | 5,833 | 2,419,548 | 0.2% | |
| No. of employees | `000 | NA | 44.9 | 0.0% | |
| Total wages/salary | Rs m | 2,179 | 0 | - | |
| Avg. sales/employee | Rs Th | NM | 33,066.5 | - | |
| Avg. wages/employee | Rs Th | NM | 0 | - | |
| Avg. net profit/employee | Rs Th | NM | 2,065.6 | - | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 10,089 | 1,486,172 | 0.7% | |
| Other income | Rs m | 257 | 0 | - | |
| Total revenues | Rs m | 10,346 | 1,486,172 | 0.7% | |
| Gross profit | Rs m | -792 | 406,989 | -0.2% | |
| Depreciation | Rs m | 361 | 120,129 | 0.3% | |
| Interest | Rs m | 2,756 | 29,191 | 9.4% | |
| Profit before tax | Rs m | -3,653 | 257,670 | -1.4% | |
| Minority Interest | Rs m | 0 | 1,171 | 0.0% | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 3,713 | -169,146 | -2.2% | |
| Tax | Rs m | 125 | -3,146 | -4.0% | |
| Profit after tax | Rs m | -65 | 92,840 | -0.1% | |
| Gross profit margin | % | -7.8 | 27.4 | -28.7% | |
| Effective tax rate | % | -3.4 | -1.2 | 280.6% | |
| Net profit margin | % | -0.6 | 6.2 | -10.4% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 9,240 | 1,003,755 | 0.9% | |
| Current liabilities | Rs m | 9,998 | 875,359 | 1.1% | |
| Net working cap to sales | % | -7.5 | 8.6 | -86.9% | |
| Current ratio | x | 0.9 | 1.1 | 80.6% | |
| Inventory Days | Days | 46 | 91 | 51.0% | |
| Debtors Days | Days | 60 | 96 | 62.5% | |
| Net fixed assets | Rs m | 10,124 | 485,417 | 2.1% | |
| Share capital | Rs m | 206 | 3,658 | 5.6% | |
| Net worth | Rs m | 7,734 | 1,650,855 | 0.5% | |
| Long term debt | Rs m | 4,889 | 759,913 | 0.6% | |
| Total assets | Rs m | 22,882 | 3,396,380 | 0.7% | |
| Interest coverage | x | -0.3 | 9.8 | -3.3% | |
| Debt to equity ratio | x | 0.6 | 0.5 | 137.3% | |
| Sales to assets ratio | x | 0.4 | 0.4 | 100.8% | |
| Return on assets | % | 11.8 | 3.6 | 327.3% | |
| Return on equity | % | -0.8 | 5.6 | -15.0% | |
| Return on capital | % | 22.3 | 4.9 | 452.4% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 11,754 | 236,819 | 5.0% | |
| From Investments | Rs m | -561 | -83,915 | 0.7% | |
| From Financial Activity | Rs m | -6,762 | -284,080 | 2.4% | |
| Net Cashflow | Rs m | 4,432 | -131,176 | -3.4% | |
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 73.16 Rs / USD
Compare ELDER PHARMA With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare ELDER PHARMA With: LUPIN FULFORD INDIA CADILA HEALTHCARE J.B.CHEMICALS PANACEA BIOTECH
Today's Market
Sensex Trades Over 600 Points Higher; Dow Futures Up by 136 Points(12:30 pm)
Share markets in India are presently trading on a strong note. The BSE Sensex is trading up by 642 points, up 1.3% at 49,206 levels.
Related Views On News
Most Popular
'Essential' Smallcap Stock Recommendations (Profit Hunter)
Jan 8, 2021The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.
Is Nifty Forming a Top (Fast Profits Daily)
Jan 8, 2021The charts are telling the bulls to be cautious.
Why Gold Hit Lower Circuit (Fast Profits Daily)
Jan 11, 2021Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
A Rare Chance to Invest in Potential Multibaggers in 2021 (Profit Hunter)
Jan 11, 2021Our ace stock picker is ready to capitalise on a big growth opportunity.
More
